Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Greg Lucier, Kenneth Beer, Philip Werschler

Premium

Epic Sciences has appointed Greg Lucier as chairman of its board of directors. Lucier was previously chairman and CEO of Life Technologies. He joins Epic as the company focuses on commercializing its circulating rare cell analysis platform, including products and services to detect circulating tumor cells.


Verisante this week named Kenneth Beer and Philip Werschler to its clinical advisory board.

Beer is a Florida-based dermatologist and a volunteer assistant professor at the University of Miami and a consulting associate with the Department of Medicine at Duke University.

Werschler is a dermatologist and skin cancer surgeon and an expert in medical and cosmetic dermatology.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.